Descartes-08 — Topline data
1Q27
Topline data from Phase 3 AURORA trial of Descartes-08 in patients with myasthenia gravis expected in 1Q27Source filing
RNAC biotech catalysts & pipeline
CARTESIAN THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
Descartes-08 — Interim data
1H27
Data from subset of patients in Phase 2 TRITON trial of Descartes-08 in myositis expected in 1H27Source filing
Descartes-08 — NDA/BLA submission
mid-2027
Cartesian remains on track to readout topline data from its Phase 3 AURORA trial of Descartes-08 in MG in the first quarter of 2027, with a BLA filing expected in mid-2027.Source filing